Search company, investor...



Private Equity | Alive

About Fenoglide

Provider of the cholesterol lowering drug for the treatment of hyperlipidemia and hypertriglyceridemia. The company's product utilizes a clinically validated reformulation technology, designed to provide improved absorption and bioavailability of the drug. The product is available in 40 mg and 120 mg tablets.

Headquarters Location

5 Concourse Parkway Suite 1800

Atlanta, Georgia, 30328,

United States


Missing: Fenoglide's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Fenoglide's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Fenoglide Frequently Asked Questions (FAQ)

  • Where is Fenoglide's headquarters?

    Fenoglide's headquarters is located at 5 Concourse Parkway, Atlanta.

  • What is Fenoglide's latest funding round?

    Fenoglide's latest funding round is Private Equity.

  • Who are the investors of Fenoglide?

    Investors of Fenoglide include HealthCare Royalty Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.